Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 15,355 | 10,007 | 25,546 | 1,381 | 3,029 |
| Gross Profit | 15,355 | 10,007 | 25,546 | 1,381 | 3,029 |
| Operating Expenses | 318,093 | 382,475 | 398,546 | 300,656 | 367,727 |
| Operating Income | -302,738 | -372,468 | -373,000 | -299,275 | -364,698 |
| Other Income | 26,259 | 34,760 | 31,027 | 8,766 | 826 |
| Pre-tax Income | -276,479 | -337,708 | -341,973 | -290,509 | -363,872 |
| Net Income Continuous | -276,479 | -337,708 | -341,973 | -290,509 | -363,872 |
| Net Income | $-276,479 | $-337,708 | $-341,973 | $-290,509 | $-363,872 |
| EPS Basic Total Ops | -1.61 | -2.36 | -2.79 | -2.59 | -3.82 |
| EPS Basic Continuous Ops | -1.61 | -2.36 | -2.79 | -2.59 | -3.82 |
| EPS Diluted Total Ops | -1.61 | -2.36 | -2.79 | -2.59 | -3.82 |
| EPS Diluted Continuous Ops | -1.61 | -2.36 | -2.79 | -2.59 | -3.82 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.36 | -2.79 | -2.69 | -2.70 |
| EBITDA(a) | $-301,830 | $-379,319 | $-378,494 | $-293,963 | $-358,721 |